Contact Us

  • Accelerating
    Therapeutic Innovation

    From Discovery to Commercialization
    Learn More
  • Your Trusted Partner in Drug Discovery, Development, and Manufacturing
    From Discovery to Commercialization
    Learn More
  • 18 IND approvals across NMPA (13), FDA (4) and MedSafe (1)
    From Discovery to Commercialization
    Learn More
123
Scroll
  • 180 +
    Global Customers
  • 18 +
    IND Clearances
  • 100%
    Submission Success
  • 300 +
    GMP Batches

End-to-End ATMP CRO & CDMO Services

Exosome Featured Image

Exosome

Explore More
Induced pluripotent stem cell (iPSC) based cell therapy CMC Services Featured Image

Induced pluripotent stem cell (iPSC) based cell therapy CMC Services

Explore More
Cell Engineering CMC services Featured Image

Cell Engineering CMC services

CAR-T, UCAR-T, TIL, NK, CAR-NK, Red Blood Cells, MSC, HSC

Explore More
Plasmid Featured Image

Plasmid

Supercoiled plasmids, Linear plasmids, LcDNA

Explore More
GMP Lentivirus Helper Plasmids Featured Image

GMP Lentivirus Helper Plasmids

Explore More

Pioneering Innovation in CRO and CDMO

More About Us
Porton Advanced provides end-to-end CDMO solutions for Advanced Therapy Medicinal Products (ATMPs), from cell banking, process and analyticals method development, cGMP production to fill&finish, covering different stages of drug development from early research, investigator-initiated trials, Investigational new drug (IND) application, clinical trials, New drug application (NDA) to commercialization.

Discover More

News & Blogs

Blogs
Safety and Transduction Efficiency of Lentivirus Helper Plasmids Featured Image
Scientific Blogs | 13 May, 2025

Safety and Transduction Efficiency of Lentivirus Helper Plasmids
News

View More

    Get In Touch With
    Porton Expert Team Today

    Clients & Partners

    View More